BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 38316520)

  • 1. DNA damage remodels the MITF interactome to increase melanoma genomic instability.
    Binet R; Lambert JP; Tomkova M; Tischfield S; Baggiolini A; Picaud S; Sarkar S; Louphrasitthiphol P; Dias D; Carreira S; Humphrey TC; Fillipakopoulos P; White R; Goding CR
    Genes Dev; 2024 Feb; 38(1-2):70-94. PubMed ID: 38316520
    [TBL] [Abstract][Full Text] [Related]  

  • 2. DNA damage-induced interaction between a lineage addiction oncogenic transcription factor and the MRN complex shapes a tissue-specific DNA Damage Response and cancer predisposition.
    Binet R; Lambert JP; Tomkova M; Tischfield S; Baggiolini A; Picaud S; Sarkar S; Louphrasitthiphol P; Dias D; Carreira S; Humphrey T; Fillipakopoulos P; White R; Goding CR
    bioRxiv; 2023 Apr; ():. PubMed ID: 37131595
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A SUMOylation-defective MITF germline mutation predisposes to melanoma and renal carcinoma.
    Bertolotto C; Lesueur F; Giuliano S; Strub T; de Lichy M; Bille K; Dessen P; d'Hayer B; Mohamdi H; Remenieras A; Maubec E; de la Fouchardière A; Molinié V; Vabres P; Dalle S; Poulalhon N; Martin-Denavit T; Thomas L; Andry-Benzaquen P; Dupin N; Boitier F; Rossi A; Perrot JL; Labeille B; Robert C; Escudier B; Caron O; Brugières L; Saule S; Gardie B; Gad S; Richard S; Couturier J; Teh BT; Ghiorzo P; Pastorino L; Puig S; Badenas C; Olsson H; Ingvar C; Rouleau E; Lidereau R; Bahadoran P; Vielh P; Corda E; Blanché H; Zelenika D; Galan P; ; Aubin F; Bachollet B; Becuwe C; Berthet P; Bignon YJ; Bonadona V; Bonafe JL; Bonnet-Dupeyron MN; Cambazard F; Chevrant-Breton J; Coupier I; Dalac S; Demange L; d'Incan M; Dugast C; Faivre L; Vincent-Fétita L; Gauthier-Villars M; Gilbert B; Grange F; Grob JJ; Humbert P; Janin N; Joly P; Kerob D; Lasset C; Leroux D; Levang J; Limacher JM; Livideanu C; Longy M; Lortholary A; Stoppa-Lyonnet D; Mansard S; Mansuy L; Marrou K; Matéus C; Maugard C; Meyer N; Nogues C; Souteyrand P; Venat-Bouvet L; Zattara H; Chaudru V; Lenoir GM; Lathrop M; Davidson I; Avril MF; Demenais F; Ballotti R; Bressac-de Paillerets B
    Nature; 2011 Oct; 480(7375):94-8. PubMed ID: 22012259
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Deciphering the Role of Oncogenic MITFE318K in Senescence Delay and Melanoma Progression.
    Bonet C; Luciani F; Ottavi JF; Leclerc J; Jouenne FM; Boncompagni M; Bille K; Hofman V; Bossis G; Marco de Donatis G; Strub T; Cheli Y; Ohanna M; Luciano F; Marchetti S; Rocchi S; Birling MC; Avril MF; Poulalhon N; Luc T; Hofman P; Lacour JP; Davidson I; Bressac-de Paillerets B; Ballotti R; Marine JC; Bertolotto C
    J Natl Cancer Inst; 2017 Aug; 109(8):. PubMed ID: 28376192
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Essential role of microphthalmia transcription factor for DNA replication, mitosis and genomic stability in melanoma.
    Strub T; Giuliano S; Ye T; Bonet C; Keime C; Kobi D; Le Gras S; Cormont M; Ballotti R; Bertolotto C; Davidson I
    Oncogene; 2011 May; 30(20):2319-32. PubMed ID: 21258399
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Microphthalmia-Associated Transcription Factor p.E318K Mutation Does Not Play a Major Role in Sporadic Renal Cell Tumors from Caucasian Patients.
    Stoehr CG; Walter B; Denzinger S; Ghiorzo P; Sturm RA; Hinze R; Moch H; Junker K; Hartmann A; Stoehr R
    Pathobiology; 2016; 83(4):165-9. PubMed ID: 26999813
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Microphthalmia-associated transcription factor controls the DNA damage response and a lineage-specific senescence program in melanomas.
    Giuliano S; Cheli Y; Ohanna M; Bonet C; Beuret L; Bille K; Loubat A; Hofman V; Hofman P; Ponzio G; Bahadoran P; Ballotti R; Bertolotto C
    Cancer Res; 2010 May; 70(9):3813-22. PubMed ID: 20388797
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A novel recurrent mutation in MITF predisposes to familial and sporadic melanoma.
    Yokoyama S; Woods SL; Boyle GM; Aoude LG; MacGregor S; Zismann V; Gartside M; Cust AE; Haq R; Harland M; Taylor JC; Duffy DL; Holohan K; Dutton-Regester K; Palmer JM; Bonazzi V; Stark MS; Symmons J; Law MH; Schmidt C; Lanagan C; O'Connor L; Holland EA; Schmid H; Maskiell JA; Jetann J; Ferguson M; Jenkins MA; Kefford RF; Giles GG; Armstrong BK; Aitken JF; Hopper JL; Whiteman DC; Pharoah PD; Easton DF; Dunning AM; Newton-Bishop JA; Montgomery GW; Martin NG; Mann GJ; Bishop DT; Tsao H; Trent JM; Fisher DE; Hayward NK; Brown KM
    Nature; 2011 Nov; 480(7375):99-103. PubMed ID: 22080950
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genetic Variants and Somatic Alterations Associated with MITF-E318K Germline Mutation in Melanoma Patients.
    Vergani E; Frigerio S; Dugo M; Devecchi A; Feltrin E; De Cecco L; Vallacchi V; Cossa M; Di Guardo L; Manoukian S; Peissel B; Ferrari A; Gallino G; Maurichi A; Rivoltini L; Sensi M; Rodolfo M
    Genes (Basel); 2021 Sep; 12(9):. PubMed ID: 34573422
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevalence of MITF p.E318K in Patients With Melanoma Independent of the Presence of CDKN2A Causative Mutations.
    Potrony M; Puig-Butille JA; Aguilera P; Badenas C; Tell-Marti G; Carrera C; Javier Del Pozo L; Conejo-Mir J; Malvehy J; Puig S
    JAMA Dermatol; 2016 Apr; 152(4):405-12. PubMed ID: 26650189
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A germline oncogenic MITF mutation and tumor susceptibility.
    Paillerets BB; Lesueur F; Bertolotto C
    Eur J Cell Biol; 2014; 93(1-2):71-5. PubMed ID: 24290354
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transcription factor MITF and remodeller BRG1 define chromatin organisation at regulatory elements in melanoma cells.
    Laurette P; Strub T; Koludrovic D; Keime C; Le Gras S; Seberg H; Van Otterloo E; Imrichova H; Siddaway R; Aerts S; Cornell RA; Mengus G; Davidson I
    Elife; 2015 Mar; 4():. PubMed ID: 25803486
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vulvar Melanoma in association with germline MITF p.E318K variant.
    Koeller DR; Schwartz A; DeSimone MS; Rana HQ; Rojas-Rudilla V; Russell-Goldman E; Laga AC; Lindeman NI; Garber JE; Ghazani AA
    Cancer Genet; 2022 Apr; 262-263():102-106. PubMed ID: 35220194
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phenotypic characterization of nevus and tumor patterns in MITF E318K mutation carrier melanoma patients.
    Sturm RA; Fox C; McClenahan P; Jagirdar K; Ibarrola-Villava M; Banan P; Abbott NC; Ribas G; Gabrielli B; Duffy DL; Peter Soyer H
    J Invest Dermatol; 2014 Jan; 134(1):141-149. PubMed ID: 23774529
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The MC1R r allele does not increase melanoma risk in MITF E318K carriers.
    Wallingford CK; Demeshko A; Krishnakripa AK; Smit DJ; Duffy DL; Betz-Stablein B; Pflugfelder A; Jagirdar K; Holland E; Mann GJ; Primiero CA; Yanes T; Malvehy J; Badenas C; Carrera C; Aguilera P; Olsen CM; Ward SV; Haass NK; Sturm RA; Puig S; Whiteman DC; Law MH; Cust AE; Potrony M; Soyer HP; McInerney-Leo AM
    Br J Dermatol; 2023 May; 188(6):770-776. PubMed ID: 36879448
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical, pathological and dermoscopic phenotype of MITF p.E318K carrier cutaneous melanoma patients.
    Ciccarese G; Dalmasso B; Bruno W; Queirolo P; Pastorino L; Andreotti V; Spagnolo F; Tanda E; Ponti G; Massone C; Drago F; Parodi A; Ghigliotti G; Pizzichetta MA; Ghiorzo P;
    J Transl Med; 2020 Feb; 18(1):78. PubMed ID: 32054529
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Integrative genomic analyses identify MITF as a lineage survival oncogene amplified in malignant melanoma.
    Garraway LA; Widlund HR; Rubin MA; Getz G; Berger AJ; Ramaswamy S; Beroukhim R; Milner DA; Granter SR; Du J; Lee C; Wagner SN; Li C; Golub TR; Rimm DL; Meyerson ML; Fisher DE; Sellers WR
    Nature; 2005 Jul; 436(7047):117-22. PubMed ID: 16001072
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An insight into understanding the coupling between homologous recombination mediated DNA repair and chromatin remodeling mechanisms in plant genome: an update.
    Banerjee S; Roy S
    Cell Cycle; 2021 Sep; 20(18):1760-1784. PubMed ID: 34437813
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cancer risks associated with the germline MITF(E318K) variant.
    Guhan SM; Artomov M; McCormick S; Njauw C-; Stratigos AJ; Shannon K; Ellisen LW; Tsao H
    Sci Rep; 2020 Oct; 10(1):17051. PubMed ID: 33051548
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mediator MED23 Links Pigmentation and DNA Repair through the Transcription Factor MITF.
    Xia M; Chen K; Yao X; Xu Y; Yao J; Yan J; Shao Z; Wang G
    Cell Rep; 2017 Aug; 20(8):1794-1804. PubMed ID: 28834744
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.